Assi HI - Search Results

1

Breast cancer knowledge in Lebanese females with positive family history.

El Maouchi P, Fakhreddine O, Shmoury AH, El Zoghbi M, Chamseddine N, Abou Zeidane R, Amhaz G, Charafeddine M, Kazarian H, Assi HI. El Maouchi P, et al. Among authors: assi hi. Medicine (Baltimore). 2023 Feb 17;102(7):e32973. doi: 10.1097/MD.0000000000032973. Medicine (Baltimore). 2023. PMID: 36800620 Free PMC article.

2

Immune toxicities and long remission duration after ipilimumab therapy for metastatic melanoma: two illustrative cases.

Assi H, Wilson KS. Assi H, et al. Curr Oncol. 2013 Apr;20(2):e165-9. doi: 10.3747/co.20.1265. Curr Oncol. 2013. PMID: 23559884 Free PMC article.

3

Mitotic index and benefit of adjuvant anthracycline-based chemotherapy in patients with early breast cancer.

Andre F, Khalil A, Slimane K, Massard C, Mathieu MC, Vignot S, Assi H, Delaloge S, Spielmann M. Andre F, et al. J Clin Oncol. 2005 May 1;23(13):2996-3000. doi: 10.1200/JCO.2005.08.046. J Clin Oncol. 2005. PMID: 15860855 Clinical Trial.

4

Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial.

Assi H, Missenard G, Terrier P, Le Pechoux C, Bonvalot S, Vanel D, Meric JB, Tursz T, Lecesne A. Assi H, et al. Curr Oncol. 2010 Nov;17(6):23-31. doi: 10.3747/co.v17i6.578. Curr Oncol. 2010. PMID: 21151406 Free PMC article.

5

Retrospective practice review of treatment of metastatic non-small-cell lung cancer with second-line erlotinib.

Melosky B, Agulnik J, Assi H. Melosky B, et al. Curr Oncol. 2008 Dec;15(6):279-85. doi: 10.3747/co.v15i6.382. Curr Oncol. 2008. PMID: 19079629 Free PMC article.

6

Efficacy, quality of life, and safety of cabazitaxel in Canadian metastatic castration-resistant prostate cancer patients treated or not with prior abiraterone.

Saad F, Winquist E, Hubay S, Berry S, Assi H, Levesque E, Aucoin N, Czaykowski P, Lattouf JB, Alloul K, Stewart J, Sridhar SS. Saad F, et al. Can Urol Assoc J. 2016 Mar-Apr;10(3-4):102-9. doi: 10.5489/cuaj.3470. Can Urol Assoc J. 2016. PMID: 27217856 Free PMC article.

7

[Expression of chemokine receptors by cancer cells].

André F, Soria JC, Assi H, Delaloge S, Spielmann M. André F, et al. Bull Cancer. 2004 Dec 1;91 Suppl 4:S254-6. Bull Cancer. 2004. PMID: 15899617 Review. French.

8

Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer.

Andre F, Cabioglu N, Assi H, Sabourin JC, Delaloge S, Sahin A, Broglio K, Spano JP, Combadiere C, Bucana C, Soria JC, Cristofanilli M. Andre F, et al. Ann Oncol. 2006 Jun;17(6):945-51. doi: 10.1093/annonc/mdl053. Epub 2006 Apr 20. Ann Oncol. 2006. PMID: 16627550 Free article.

9

Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trial.

Thompson JA, Hamid O, Minor D, Amin A, Ron IG, Ridolfi R, Assi H, Berman D, Siegel J, Weber JS. Thompson JA, et al. J Immunother. 2012 Jan;35(1):73-7. doi: 10.1097/CJI.0b013e31823735d6. J Immunother. 2012. PMID: 22130164 Clinical Trial.

10

A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma.

Weber J, Thompson JA, Hamid O, Minor D, Amin A, Ron I, Ridolfi R, Assi H, Maraveyas A, Berman D, Siegel J, O'Day SJ. Weber J, et al. Clin Cancer Res. 2009 Sep 1;15(17):5591-8. doi: 10.1158/1078-0432.CCR-09-1024. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671877 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters